Director, Regional Ecosystem Lead

Position Description Summary CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

Main Responsibilities & Accountabilities

Lead sourcing and represent CSL within the regional innovation ecosystem, actively sourcing opportunities aligned with all TA strategies and portfolio priorities.

Maintain and expand strategic relationships with universities, incubators, accelerators, venture capital firms, and local organizations to amplify CSL’s external innovation priorities.

Partner closely with TA Search Leads to conduct regional searches, plan engagements and conferences, and share regional insights and updates.

Serve as a senior member of deal teams occurring in each region, supporting transactions from identification through due diligence and help lead relationships with external partners through deal close.

Organize and represent CSL at local external innovation events, such as CSL-hosted innovation days, and ensure strong visibility in the ecosystem.

Qualifications & Experience Requirements

12+ years in biopharma, external innovation, or business development with strong regional network and ecosystem knowledge.

Advanced degree required (PhD, MD, or equivalent).

Proven ability to source and evaluate external opportunities and lead deal execution.

Strong relationship-building skills with academic, biotech, and investment communities

Location: Melbourne, CBD

Hybrid Working

About CSL Behring CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

Our Benefits For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

You Belong at CSL At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

Equal Opportunity Employer CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.

#J-18808-Ljbffr